Pneumonia, Bacterial - 26 Studies Found Completed : Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia : Pneumonia, Bacterial : 2007-10-01 : Drug: daptomycin Completed : A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia : Pneumonia, Bacterial : 2005-05-24 : Drug: Ceftriaxone 1000mg iv da Recruiting : A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia : Pneumonia, Bacterial : 2015-05-28 : Drug: ME1100 inhalation solution Completed : Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae : Pneumonia, Bacterial : 2007-10-04 : Drug: daptomycin Completed : Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia : Pneumonia, Bacterial : 2013-10-22 : Drug: Amikacin fosfomycin inhalation solution Completed : Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia : Community-Acquired Bacterial Pneumonia : 2010-07-22 : Drug: Levofloxacin Completed : Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia : Pneumonia, Bacterial Community-acquired : 2012-01-30 : Drug: Ceftaroline 600 mg Q12h Completed : Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit : Pneumonia, Bacterial : 2012-03-07 : Other: 5 Days of Antibiotics T Recruiting : Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) : Bacterial Pneumonia : 2015-07-07 : Drug: Imipenem Imipenem 500 mg Terminated : Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia : Community-Acquired Bacterial Pneumonia (CABP) : 2010-09-07 : Drug: JNJ-32729463 150 mg intr Next >>>
